These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 18084329)
21. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
22. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684 [TBL] [Abstract][Full Text] [Related]
23. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Lippa MS; Strockbine LD; Le TT; Branstetter DG; Strathdee CA; Holland PM Apoptosis; 2007 Aug; 12(8):1465-78. PubMed ID: 17440816 [TBL] [Abstract][Full Text] [Related]
24. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731 [TBL] [Abstract][Full Text] [Related]
25. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function. Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164 [TBL] [Abstract][Full Text] [Related]
26. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation. Yang BF; Xiao C; Li H; Yang SJ Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862 [TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Ganten TM; Koschny R; Haas TL; Sykora J; Li-Weber M; Herzer K; Walczak H Hepatology; 2005 Sep; 42(3):588-97. PubMed ID: 16037944 [TBL] [Abstract][Full Text] [Related]
28. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells. Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595 [TBL] [Abstract][Full Text] [Related]
29. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Laguinge LM; Samara RN; Wang W; El-Deiry WS; Corner G; Augenlicht L; Mishra L; Jessup JM Cancer Res; 2008 Feb; 68(3):909-17. PubMed ID: 18245494 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Xiao C; Yang BF; Song JH; Schulman H; Li L; Hao C Exp Cell Res; 2005 Mar; 304(1):244-55. PubMed ID: 15707589 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058 [TBL] [Abstract][Full Text] [Related]
33. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
34. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. Kim YH; Lee YJ J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854 [TBL] [Abstract][Full Text] [Related]
35. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339 [TBL] [Abstract][Full Text] [Related]
36. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244 [TBL] [Abstract][Full Text] [Related]
37. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y; Zhang B Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831 [TBL] [Abstract][Full Text] [Related]
38. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells. Tseng HY; Chen LH; Ye Y; Tay KH; Jiang CC; Guo ST; Jin L; Hersey P; Zhang XD Carcinogenesis; 2012 Oct; 33(10):1871-81. PubMed ID: 22791814 [TBL] [Abstract][Full Text] [Related]
39. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346 [TBL] [Abstract][Full Text] [Related]